MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Virtual Reality–Based Rehabilitation for Freezing of Gait in Parkinson’s Disease: Implications for Cognitive–Motor Integration: A Systematic Review

    W. Phuenpathom, R. Bhidayasiri, S. Lewis (Sydney, Australia)

    Objective: To evaluate the effects of VR-based rehabilitation on freezing of gait and gait performance in individuals with PD and FOG. Background: Freezing of gait…
  • 2026 International Congress

    Association of Coffee Consumption and Smoking with Cognitive Function in Patients with Early Parkinson’s Disease

    SM. Choi, HL. Lee (Gwangju, Republic of Korea)

    Objective: This study investigated cognitive differences among patients with early-stage Parkinson's disease (PD) according to coffee consumption and smoking status. Background: PD is frequently accompanied…
  • 2026 International Congress

    Reduced Whole-blood Energy Metabolism in Parkinson’s Disease.

    Y. Mizutani, R. Ohdake, Y. Maeda, T. Maeda, R. Nagao, K. Kawabata, S. Shima, A. Ueda, M. Ito, H. Watanabe (Toyoake, Japan)

    Objective: We aimed to investigate the dynamics of whole-blood energy metabolism in Parkinson’s disease (PD) and evaluate its clinical relevance. Background: Emerging evidence indicates that…
  • 2026 International Congress

    Re-evaluating Olfactory Testing and Cardiac 123I-MIBG Scintigraphy in the MDS Clinical Diagnostic Criteria for Parkinson’s Disease

    T. Nukariya, M. Seki, T. Osada, J. Ebina, K. Suzuki, R. Sengoku, T. Hatano, H. Murakami, K. Sakuishi, M. Shiraishi, Y. Shimo, H. Terashi, H. Nagayama, H. Nakajima, K. Takahashi, S. Nogawa, Y. Okuma, F. Yoshii, M. Iijima, N. Hattori (Tokyo, Japan)

    Objective: To determine whether routine implementation of cardiac 123I-MIBG scintigraphy improves the diagnostic performance of the Movement Disorder Society (MDS) “clinically probable Parkinson’s disease (PD)”…
  • 2026 International Congress

    Basal Ganglia Hypointensity Associated with Glucose Transporter Type 1 Deficiency Syndrome (GLUT1-DS)

    C. Jiménez Clopés, Y. Estrella Domínguez, J. Balsa Vázquez, A. Rojo Sebastián (Alcalá de Henares, Madrid, Spain)

    Objective: To present a new case of glucose transporter type 1 deficiency syndrome (GLUT1-DS) diagnosed in adulthood and to describe the associated radiological findings. Background:…
  • 2026 International Congress

    Probable Corticobasal Syndrome Presenting as Writer’s Cramp: A Case Report

    B. Dias, K. Alves, T. Goncalves, D. Faria, R. Pinto, S. Silva (Sao Paulo, Brazil)

    Objective: To describe an unusual initial presentation of corticobasal syndrome manifesting as writer’s cramp, a task-specific focal dystonia, and to discuss its compatibility with the…
  • 2026 International Congress

    Real-World Survival, Healthcare Access, and Medication Patterns in Atypical Parkinsonian Disorders: A Multi-System EHR Analysis

    J. Fenn, N. Mcfarland (Gainesville, USA)

    Objective: To assess regional prevalence, demographics, survival, neurology access, and medication utilization in atypical parkinsonian disorders. Background: Progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), and…
  • 2026 International Congress

    Restless leg syndrome in Parkinson’s disease: A systematic review on the prevalence, demographic, clinical profile and diagnostic criteria

    A. Payus, J. Sringean, R. Bhidayasiri (kota kinabalu, Malaysia)

    Objective: This systematic review aims to estimate the pooled prevalence of restless leg syndrome (RLS) in Parkinson’s disease (PD) and illustrate the updated understanding of…
  • 2026 International Congress

    IncobotulinumtoxinA for the Treatment of Lower Limb Spasticity in Children and Adolescents with Cerebral Palsy Evaluation of Lower Limb IncobotulinumtoxinA Efficacy (ELLIE)

    I. Makedonska (Dnipro, Ukraine)

    Objective: To investigate the use of incobotulinumtoxinA in the treatment of lower limb spasticity in children and adolescents with cerebral palsy (CP). Background: Spasticity associated…
  • 2026 International Congress

    The Cats-and-Dogs Test Predicts Cognitive Impairment in Parkinson’s Disease in a Diverse Population

    KC. Dey, D. Mair, T. Zannat, A. Zirra, E. Camboe, E. Bhadra, ABS. Haque, R. Weil, D. Gallagher, C. Budu, T. Haque, S. Hussain-Ali, N. Mukadam, A. Habib, CR. Marshall, AJ. Noyce, S. Waters (London, United Kingdom)

    Objective: To determine whether the Cats-and-Dogs visuoperceptual task (CnD) predicts cognitive impairment (CI) in Parkinson’s disease (PD) in a diverse population in East London and…
  • « Previous Page
  • 1
  • …
  • 119
  • 120
  • 121
  • 122
  • 123
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley